Medifast, Inc. provided earnings guidance for the full-year 2022. The company expects full-year 2022 revenue to be in the range of $1.72 billion to $1.79 billion and full-year 2022 diluted EPS to be in the range of $14.50 to $16.00.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.2 USD | -2.10% | +1.13% | -62.69% |
04-30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
04-30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.69% | 275M | |
+4.94% | 7.59B | |
-0.05% | 6.07B | |
-3.33% | 3.85B | |
-11.92% | 3.55B | |
-10.53% | 1.28B | |
-33.68% | 1.03B | |
+14.51% | 971M | |
-9.74% | 907M | |
-14.69% | 813M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast, Inc. Provides Earnings Guidance for the Full-Year 2022